Terms: = Cervical cancer AND CD79B, ENSG00000007312, 974, P40259, IGB, B29 AND Treatment
17 results:
1. Discovery and technical validation of high-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countries.
Fackler MJ; Pleas M; Li Y; Soni A; Xing D; Cope L; Ali S; Van Le Q; Van Nguyen C; Pham HT; Duong LM; Vanden Berg E; Wadee R; Michelow P; Chen WC; Joffe M; Fjeldbo CS; Lyng H; Sukumar S
Clin Epigenetics; 2024 Apr; 16(1):56. PubMed ID: 38643219
[TBL] [Abstract] [Full Text] [Related]
2. treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors.
Ye Y; Li Z; Kang S; Yang Y; Ling B; Wang L; Yao J; Li P; Wang X; Gong S; Fan H; Kong Y; Cao Y; Lang J; Liu P; Chen C
BMC Cancer; 2023 May; 23(1):421. PubMed ID: 37161372
[TBL] [Abstract] [Full Text] [Related]
3. Convolutional Neural Networks for Classifying cervical cancer Types Using Histological Images.
Li YX; Chen F; Shi JJ; Huang YL; Wang M
J Digit Imaging; 2023 Apr; 36(2):441-449. PubMed ID: 36474087
[TBL] [Abstract] [Full Text] [Related]
4. Clavien-Dindo classification and risk prediction model of complications after robot-assisted radical hysterectomy for cervical cancer.
Ling H; Wang G; Yi B; Li Z; Zhu S
J Robot Surg; 2023 Apr; 17(2):527-536. PubMed ID: 35913623
[TBL] [Abstract] [Full Text] [Related]
5. Sexual Inactivity During the Last 4 Weeks in Long-Term cervical cancer Survivors: Prevalence and Associated Factors.
Dahl AA; Bentzen AG; Fosså SD; Hess SL; Steen R; Vistad I; Kiserud CE
J Sex Med; 2020 Jul; 17(7):1359-1369. PubMed ID: 32336554
[TBL] [Abstract] [Full Text] [Related]
6. Preferences for follow up in long-term survivors after cervical cancer.
Vistad I; Lindemann K; Bentzen AG; Dahl AA; Steen R; Kiserud C
Acta Obstet Gynecol Scand; 2020 Sep; 99(9):1253-1259. PubMed ID: 32232835
[TBL] [Abstract] [Full Text] [Related]
7. Relation between the number of board-certified gynecologic oncologists per hospital and survival of cervical cancer.
Yagi A; Ueda Y; Nakagawa S; Morimoto A; Matsuzaki S; Kobayashi E; Kimura T
J Obstet Gynaecol Res; 2019 Jun; 45(6):1160-1166. PubMed ID: 30843312
[TBL] [Abstract] [Full Text] [Related]
8. [Paclitaxel containing chemotherapeutic regimens in first line and reintroduced palliative treatment of metastatic cervical cancer].
Kullmann T; Sipőcz I; Agyemang-Prempeh K; Barna O; Pintér T
Orv Hetil; 2018 Jun; 159(24):974-977. PubMed ID: 29888659
[TBL] [Abstract] [Full Text] [Related]
9. Survival effect of laparoscopic para-aortic staging in locally advanced cervical cancer: a retrospective cohort analysis.
Pomel C; Martinez A; Bourgin C; Beguinot M; Benoit C; Naik R; Dauplat J; Lebouedec G; Ferron G
BJOG; 2017 Jun; 124(7):1089-1094. PubMed ID: 28128517
[TBL] [Abstract] [Full Text] [Related]
10. Robotic-assisted modified retroauricular cervical approach: initial experience in Latin America.
Chulam TC; Lira RB; Kowalski LP
Rev Col Bras Cir; 2016; 43(4):289-91. PubMed ID: 27679950
[TBL] [Abstract] [Full Text] [Related]
11. Cost effectiveness of concurrent gemcitabine and cisplatin with radiation followed by adjuvant gemcitabine and cisplatin in patients with stages IIB to IVA carcinoma of the cervix.
Phippen NT; Leath CA; Chino JP; Jewell EL; Havrilesky LJ; Barnett JC
Gynecol Oncol; 2012 Nov; 127(2):267-72. PubMed ID: 22892361
[TBL] [Abstract] [Full Text] [Related]
12. Adverse obstetrical outcomes after treatment of precancerous cervical lesions: a Belgian multicentre study.
Simoens C; Goffin F; Simon P; Barlow P; Antoine J; Foidart JM; Arbyn M
BJOG; 2012 Sep; 119(10):1247-55. PubMed ID: 22804838
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic significance of cyclooxygenase-2 in cervical cancer: a meta-analysis.
Huang M; Chen Q; Xiao J; Liu C; Zhao X
Int J Cancer; 2013 Jan; 132(2):363-73. PubMed ID: 22729746
[TBL] [Abstract] [Full Text] [Related]
14. Topotecan for the treatment of recurrent and stage IVB carcinoma of the cervix.
Paton F; Paulden M; Saramago P; Manca A; Misso K; Palmer S; Eastwood A
Health Technol Assess; 2010 May; 14 Suppl 1():55-62. PubMed ID: 20507804
[TBL] [Abstract] [Full Text] [Related]
15. Preoperative [18F]FDG PET/CT maximum standardized uptake value predicts recurrence of uterine cervical cancer.
Chung HH; Nam BH; Kim JW; Kang KW; Park NH; Song YS; Chung JK; Kang SB
Eur J Nucl Med Mol Imaging; 2010 Aug; 37(8):1467-73. PubMed ID: 20352210
[TBL] [Abstract] [Full Text] [Related]
16. [Persistent and recurrent gynecologic malignant tumor treated within one year: analysis of 1,753 cases from 61 hospitals in China].
Cao Z; Yu S
Zhonghua Fu Chan Ke Za Zhi; 1996 Jul; 31(7):417-21. PubMed ID: 9275416
[TBL] [Abstract] [Full Text] [Related]
17. Carcinoma of the vocal cord: results of treatment and time-dose relationships.
Kim JC; Elkin D; Hendrickson FR
Cancer; 1978 Sep; 42(3):1114-9. PubMed ID: 698909
[TBL] [Abstract] [Full Text] [Related]
